MaxCyte, Inc. logo MXCT - MaxCyte, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 4
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $6.00 DETAILS
HIGH: $6.00
LOW: $6.00
MEDIAN: $6.00
CONSENSUS: $6.00
UPSIDE: 387.80%

About MaxCyte, Inc. (https://www.maxcyte.com)

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Key Executives

NAME TITLE DOB SALARY
Maher Masoud President, Chief Executive Officer & Executive Director 1976 $919,082 USD
Parmeet Ahuja Chief Financial Officer 1969 $700,557 USD
Ana-Paula Martins Fernandes Senior Vice President of Global Sales
Jack Horgan Senior Vice President of Corporate Development
Jay Gelfman Chief Operations Officer
Jill Mayer Senior Vice President of Human Resources

Company Peers

Peer analysis pending, check back in 1-2 minutes.